Phase I-II study of weekly 5-fluorouracil and 5,10-methylene- tetrahydrofolate in patients with advanced gastrointestinal and breast cancer

Cancer Journal

Volumn 10, Issue 5, 1997, Pages 266-273

  Carlsson, G ^a   Odin, E ^a   Larsson, P A ^a   Frosing, R ^a   Spears, C P ^a   Gustavsson, B ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

5,10 Methylene tetrahydrofolate; 5 Fluorouracil; Breast cancer; Gastrointestinal cancer; Pharmacodynamics; Pharmacokinetics

Indexed keywords

FLUOROURACIL; TETRAHYDROFOLIC ACID DERIVATIVE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL CARCINOMA; HUMAN; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; TREATMENT OUTCOME;

EID: 0030690168     PISSN: 07657846     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)